Coloplast launches new fistula product

Coloplast's Ostomy Care Division has developed a new type of fistula pouch that can make everyday life easier for patients with fistulas in exuding wounds.

 

For the first time, Coloplast is launching a new type of fistula pouch, Fistula & Wound Management System that can treat fistulas in exuding wounds. Almost 25,000 persons worldwide suffer from fistulas each year. The product will initially be marketed in the USA.

A fistula is an involuntary passage from the bowel organs out through the stomach that is created by the body. The condition is typically caused by inflammation of the bowel organs (e.g. Morbus Crohn) or radiation damage. The condition may result in the patient developing large exuding wounds around the fistula, resulting in the patient requiring a temporary stoma. At worst, the bowel system may fail, resulting in the patient needing a permanent stoma.

Coloplast has not previously marketed products of this type. The potential market for fistula pouches corresponds to just under 2% of Coloplast's existing market for ostomy products. The product is sold to hospitals, which use it in their treatment of patients for up to three months at a time.

The new product has been developed in close collaboration with stoma care nurses, who often treat fistulas in exuding wounds.